Related Experiment Videos
[Definition and validation of quality indicators of prescription in primary care]
M A Torrecilla-Rojas1, M Pedregal-González, M O Caraballo-Camacho
1Farmacia, Distrito Condado-Campiña, Huelva, Spain. atorrec@sefap.org
Objective:
To define and validate a battery of prescription indicators on the use of anti-hypertensives, lipid-lowerers, diabetes drugs, and insulin, as measurements of family doctors' quality of prescription in primary health care.
Design:
Transversal, descriptive study.
Setting:
Two primary care health districts, Camas and Sierra Norte, Spain.
Participants:
Eighty three family doctors, 94.32% of the doctors in the study area. DEFINITION AND VALIDATION OF INDICATORS: To construct the prescription indicators, we used evidence found in the scientific bibliography available. To validate it, we analysed its statistical relationship with a series of selected clinical tests, collected from the clinical records.
Results:
For each doctor, there was a statistically significant relationship between the index of quality of prescription and the clinical quality seen in the records (P=.004). The variables of age, sex, and training fine-tuned the model.
Conclusions:
There is a statistically significant relationship between a good prescription indicator and proper control of intermediate health variables.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Formulating and Validating Nursing Diagnosis II
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Data Validation
Key parameters for method validation include:
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Regimen: Individualization